Intratympanic vs systemic steroids for sudden sensorineural hearing loss: a systematic review of recovery
DOI:
https://doi.org/10.51798/sijis.v7i2.1379Keywords:
Sudden sensorineural hearing loss, intratympanic steroids, systemic corticosteroids, hearing recovery, systematic reviewAbstract
Background: Idiopathic sudden sensorineural hearing loss (ISSNHL) is an otologic emergency with an incidence of 5–27 per 100,000 persons per year. The primary treatment method is corticosteroids, although the most effective way of administration is a controversial issue. The aim of the study is to compare the results of hearing recovery in intratympanic and systemic corticosteroid in ISSNHL. Methods: We used PRISMA to systematically search PubMed, Scopus and Web of Science (2015–2025) to identify randomized controlled trials and prospective comparative studies. The extraction of data was done on the improvement of pure-tone averages, recovery rates and complications. Cochrane RoB 2 was used to assess the risk of bias. Findings: The number of studies and patients included was 17 and 1,649 respectively. In most studies, recovery rates ranged from 60% to 70% across studies. The largest RCT with a 67.3% efficacy rate versus 57.4% with systemic alone (n=47) was combined systemic-intratympanic therapy (n=156) (p>0.05). Salvage intratympanic therapy (n=43) yielded a mean hearing gain of 13.6 dB as compared to no improvement with observation (n=48). Such prognostic variables as vertigo (p=0.039), cardiovascular comorbidity (p=0.02) and initial severity of hearing loss (p=0.033) had a significant impact. Conclusions: Intratympanic corticosteroids have the same efficacy as systemic therapy in the treatment of primary ISSNHL and have positive safety profiles. Severe cases may be helped by combined therapy. In case of a failed systemic treatment, salvage intratympanic therapy works.
References
Ajduk, J., Peček, M., Kelava, I., Žaja, R., Ries, M., & Košec, A. (2023). Comparison of intratympanic steroid and hyperbaric oxygen salvage therapy hearing outcomes in idiopathic sudden sensorineural hearing loss: A retrospective study. Ear and Hearing, 44(4), 894-899.
Amizadeh, M., Fazlinezhad, F., Ranjbar, M., & Hasanalifard, M. (2025). The efficacy of methylprednisolone acetate nanogel in treating patients with sudden sensorineural hearing loss. Scientific Reports, 15(1), 12342.
Chang, W. T., Zee, B., Lee, H. S. H., & Tong, M. C. F. (2020). Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial. American Journal of Otolaryngology, 41(4), 102515.
Cho, I., Lee, H. M., Choi, S. W., Kong, S. K., Lee, I. W., Goh, E. K., & Oh, S. J. (2018). Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: A randomized controlled trial. Audiology and Neurotology, 23(4), 199-207.
Choo, O. S., Yang, S. M., Park, H. Y., Lee, J. B., Jang, J. H., Choi, S. J., & Choung, Y. H. (2017). Differences in clinical characteristics and prognosis of sudden low- and high-frequency hearing loss. Laryngoscope, 127(8), 1878-1884.
Ermutlu, G., Süslü, N., Yılmaz, T., & Saraç, S. (2017). Sudden hearing loss: An effectivity comparison of intratympanic and systemic steroid treatments. European Archives of Oto-Rhino-Laryngology, 274(10), 3585-3591.
Huang, J., Yang, L., Cao, X., & Wang, W. (2021). Differences in hearing recovery following intratympanic alone or intravenous dexamethasone with rescue intratympanic steroids for sudden sensorineural hearing loss: A randomised trial. Clinical Otolaryngology, 46(3), 546-551.
Kovács, M., Uzsaly, J., Bodzai, G., Pap, I., Lippai, B., Dergez, T., Németh, A., Gerlinger, I., Szanyi, I., & Bakó, P. (2024). Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis. American Journal of Otolaryngology, 45(1), 104099.
Li, D. B., Zhou, S., & Xu, W. J. (2017). Intratympanic dexamethasone versus post-auricular subperiosteal injection of methylprednisolone treatment for sudden hearing loss. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 31(16), 1265-1268.
Mehta, N., & Mehta, S. (2021). Comparative evaluation of injection dexamethasone and oral glycerol versus injection dexamethasone alone in the treatment of sudden onset sensorineural deafness. Ear, Nose and Throat Journal, 100(3_suppl), 317S-324S.
Ni, M. M., Liu, L., Zhao, R., Nie, M., & Yang, X. H. (2018). Evaluation of the effect of systemic and intratympanic dexamethasone combination therapy on sudden deafness. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 32(9), 656-660. https://doi.org/10.13201/j.issn.1001-1781.2018.09.004
Sevil, E., Bercin, S., Muderris, T., Gul, F., & Kiris, M. (2016). Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology, 273(9), 2419-2426.
Si, Y., Jiang, H. L., Chen, Y. B., Chu, Y. G., Chen, S. J., Chen, X. M., He, W. H., Zheng, Y. Q., & Zhang, Z. G. (2018). Round window niche drilling with intratympanic steroid is a salvage therapy of sudden hearing loss. Audiology and Neurotology, 23(6), 309-315.
Sialakis, C., Iliadis, C., Frantzana, A., Ouzounakis, P., & Kourkouta, L. (2022). Intratympanic versus systemic steroid therapy for idiopathic sudden hearing loss: A systematic review and meta-analysis. Cureus, 14(3).
Sun, R. X., Zhao, Y., & Liu, J. (2016). Intratympanic budesonide injection for treatment of refractory sudden sensorineural hearing loss. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 30(12), 972-977.
Swachia, K., Sharma, D., & Singh, J. (2016). Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. Journal of Basic and Clinical Physiology and Pharmacology, 27(4).
Tong, B., Wang, Q., Dai, Q., Hellstrom, S., & Duan, M. (2021). Efficacy of various corticosteroid treatment modalities for the initial treatment of idiopathic sudden hearing loss: A prospective randomized controlled trial. Audiology and Neurotology, 26(1), 45-52.
Tsounis, M., Psillas, G., Tsalighopoulos, M., Vital, V., Maroudias, N., & Markou, K. (2018). Systemic, intratympanic and combined administration of steroids for sudden hearing loss: A prospective randomized multicenter trial. European Archives of Oto-Rhino-Laryngology, 275(1), 103-110.
Wang, S. Y., Fu, W. T., Yu, M., Sun, A., Sun, J., & Li, G. (2025). Efficacy analysis of intratympanic injection of dexamethasone at different concentrations for the treatment of unilateral idiopathic sudden sensorineural hearing loss. American Journal of Otolaryngology, 46(2), 104603.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Madelayne Cecilia Enriquez Cobos, Sofía Alejandra Galvis Garrido, Mónica Alexandra Caiza Asitimbay, Hannia Bertha Matt Hernandez, Daniel Sebastian Zamora Gutierrez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
